Browsing by Author "Vlajković, Ana (57195621556)"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score(2017) ;Polovina, Marija (35273422300) ;Đikić, Dijana (57195958586) ;Vlajković, Ana (57195621556) ;Vilotijević, Matej (57195621387) ;Milinković, Ivan (51764040100) ;Ašanin, Milika (8603366900) ;Ostojić, Miodrag (34572650500) ;Coats, Andrew J.S. (35395386900)Seferović, Petar M. (6603594879)Background In addition to thromboembolism, atrial fibrillation (AF) may also predispose to major adverse cardiovascular events (MACE) attributable to coronary artery disease (CAD), including myocardial infarction (MI). The 2MACE score (2 points - Metabolic syndrome and Age ≥ 75 years, 1 point - MI/revascularization, Congestive heart failure/ejection-fraction < 40%, and thrombo-Embolism) was recently proposed to help identify AF patients at risk of MACE. We assessed the predictive validity of the 2MACE score for MACE occurrence in AF patients free of CAD at baseline. Methods Non-valvular AF patients (n = 794) without CAD (mean-age, 62.5 ± 12.1 years, metabolic syndrome, 34.0%; heart failure/ejection-fraction < 40%, 25.7%; thromboembolism, 9.7%) were prospectively followed for 5 years, or until MACE (composite of non-fatal/fatal MI, revascularization and cardiovascular death). At inclusion, CAD was excluded by medical history, exercise-stress testing and/or coronary angiography. Also, the 2MACE score was determined. Results At follow-up, 112 patients experienced MACE (2.8%/year). The 2MACE score demonstrated adequate discrimination (C-statistic, 0.699; 95% confidence interval [CI], 0.648–0.750; P < 0.001) and calibration (Hosmer-Lemeshow P = 0.79) for MACE. The score was significantly associated with MACE, with the adjusted Hazard Ratio (aHR) of 1.56 (95%CI, 1.35–1.73; P < 0.001). As for individual outcomes, the score predicted MI (n = 46; aHR, 1.49; 95%CI 1.23–1.80), revascularization (n = 32; aHR, 1.41; 95%CI, 1.11–1.80) and cardiovascular death (n = 34; aHR, 1.43; 95%CI, 1.14–1.81), all P < 0.001. Conclusions The 2MACE score successfully predicts future MACE, including incident MI, coronary revascularization and cardiovascular death in AF patients free of CAD at baseline. It may have a role in risk-stratification and primary prevention of MACE in AF patients. © 2017 Elsevier Ireland Ltd - Some of the metrics are blocked by yourconsent settings
Publication Analgesia in the palliative care of children(2020) ;Simić, Dušica (16679991000) ;Vlajković, Ana (57195621556) ;Budić, Ivana (16548855200) ;Milenović, Miodrag (36612130700)Stević, Marija (55804941500)Due to the increasing incidence of terminal illnesses in children, there is great urgency within pediatric medicine to give these patients the best palliative care possible. The main focus of palliative care is to alleviate suffering resulting from the psychophysical condition of the child, which is mostly due to physical pain. The first phase of managing pain in palliative care is quantifying and qualifying pain levels, although this is sometimes difficult to do with pediatric patients. In addition to implementing strategies that alleviate or remove pain for patients, it is also crucial to give patients and their families a feeling of full control over pain. In practice, non-pharmacological and pharmacological methods of analgesia are present. Pharmacological methods include non-opioid and opioid analgesics, followed by co-analgesics as well as methods of regional anesthesia. In order to give these patients the best care possible, it is necessary that the approach be individual, multimodal, multidisciplinary, and considerate of every detail. © 2020, Serbia Medical Society. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Patients’ knowledge and perspectives on vitamin K antagonists for stroke prevention in atrial fibrillation: Implications for treatment quality(2017) ;Polovina, Marija (35273422300) ;Đjikić, Dijana (35798144600) ;Vlajković, Ana (57195621556)Vilotijević, Matej (57195621387)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication Pediatric burn injury: key points for the anaesthesiologist(2023) ;Simić, Dušica (16679991000) ;Budić, Ivana (16548855200) ;Vlajković, Ana (57195621556) ;Milenovic, Miodrag (36612130700)Stević, Marija (55804941500)Burns are the eleventh leading cause of deaths in childhood and the fifth most common cause of non-fatal childhood injury, and most often occur in children under 4. 80% to 90% of all severe burns occur in low to middle income countries. Anaesthesiologists are crucial members of the multi-disciplinary team caring for children with burns. Provision of adequate analgesia, sedation, anesthesia and intensive care treatment are roles of anaesthesiologists and non-physician anaesthetists. There are several anaesthetic challenges with managing the child with burns such as a potential difficult airway, challenging intravascular line placement, water and electrolyte disturbances, altered temperature regulation, sepsis, cardiovascular and respiratory insufficiency, altered pharmacokinetic and pharmacodynamics pathways. The majority of critical adverse events in burn injured patients are associated with the airway and hemodynamic instability. The specific anaesthetic technique required depends on the individual patient pathophysiology condition. With the progress in burn care trauma protocols and with the development of multidisciplinary teams at special burn units, outcomes have improved over the past two decades. This review provides insights into existing therapeutic approaches for the management of paediatric burns. © 2023, World Federation of Societies of Anesthesiologists. All rights reserved.
